-
-
-
-
-
-
-
Gilead Sciences (GILD) Reiterated at Overweight by Cantor Fitzgerald
-
-
-
-
-
-
-
Maxim Group Upgrades Gilead Sciences (GILD) to Buy
-
-
-
-
-
-
-
Gilead Sciences (GILD) call put ratio 1.9 calls to 1 put with a focus on June options into quarter results
-
-
-
-
-
-
-
BMO Capital Reiterates Outperform Rating on Gilead Sciences (GILD)
-
-
-
-
-
-
-
UBS Reiterates Buy Rating on Gilead Sciences (GILD)
-
-
-
-
-
-
-
Gilead to buy Ouro Medicines for up to $2.2 billion
-
-
-
-
-
-
-
Gilead HIV drug combination maintains viral suppression in phase 3 trials
-
423,328 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

